Changes in Cyclooxygenase-2’s Expression, and PGE2 ’s and 6-keto-PGF1α’s Levels in the Presence of the Muscarinic Acethylcholine Receptor Antibody in Primary Sjögren Syndrome
International Journal of Dentistry and Oral Health · 2015
DOI: 10.16966/2378-7090.115 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Dentistry and Oral Health, 2015. Verfasst von Reina Silvia.
Abstract (Originalsprache)
Enzyme-linked immunoabsorbent assay (ELISA) was performed in the presence or absence of different enzymatic and specific receptors’ antagonist drugs. The levels and the generation of PGE2, 6-keto-PGF1α and cyclic AMP (cAMP) in rat submandibular gland acini’s preparations and in serum from pSS patients were measured in the presence of pSS IgG anti M3 peptide. COX-2 mRNA gene’s expression at Real Time PCR was done in acini’s preparations from rat submandibular gland in the presence of the autoantibodies alone or once previously incubated with different inhibitors
Zitieren
APA
Silvia, R. (2015). Changes in Cyclooxygenase-2’s Expression, and PGE2 ’s and 6-keto-PGF1α’s Levels in the Presence of the Muscarinic Acethylcholine Receptor Antibody in Primary Sjögren Syndrome. International Journal of Dentistry and Oral Health. https://doi.org/10.16966/2378-7090.115
Vancouver
Silvia R. Changes in Cyclooxygenase-2’s Expression, and PGE2 ’s and 6-keto-PGF1α’s Levels in the Presence of the Muscarinic Acethylcholine Receptor Antibody in Primary Sjögren Syndrome. International Journal of Dentistry and Oral Health. 2015. doi:10.16966/2378-7090.115
BibTeX
@article{Silvia2015,
author = {Silvia, Reina},
title = {Changes in Cyclooxygenase-2’s Expression, and PGE2 ’s and 6-keto-PGF1α’s Levels in the Presence of the Muscarinic Acethylcholine Receptor Antibody in Primary Sjögren Syndrome},
journal = {International Journal of Dentistry and Oral Health},
year = {2015},
doi = {10.16966/2378-7090.115}
}
EUVIMED